Results 11 to 20 of about 6,246,317 (338)

The burden and risks of emerging complications of diabetes mellitus

open access: yesNature Reviews Endocrinology, 2022
The traditional complications of diabetes mellitus are well known and continue to pose a considerable burden on millions of people living with diabetes mellitus.
Dunya Tomic, J. Shaw, D. Magliano
semanticscholar   +1 more source

Symptoms, complications and management of long COVID: a review

open access: yesJournal of the Royal Society of Medicine, 2021
Globally, there are now over 160 million confirmed cases of COVID-19 and more than 3 million deaths. While the majority of infected individuals recover, a significant proportion continue to experience symptoms and complications after their acute illness.
O. Aiyegbusi   +11 more
semanticscholar   +1 more source

Hematological findings and complications of COVID‐19

open access: yesAmerican journal of hematology/oncology, 2020
COVID‐19 is a systemic infection with a significant impact on the hematopoietic system and hemostasis. Lymphopenia may be considered as a cardinal laboratory finding, with prognostic potential.
E. Terpos   +8 more
semanticscholar   +1 more source

Emerging Targets in Type 2 Diabetes and Diabetic Complications

open access: yesAdvancement of science, 2021
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects.
Sevgican Demir   +3 more
semanticscholar   +1 more source

A cohort study of membranous nephropathy, primary or secondary

open access: yesBMC Nephrology, 2021
Background Although IgG4 deposit against phospholipase A2 receptor (anti-PLA2R) is predominantly presented in the renal biopsy of patients with primary membranous nephropathy (MN), its diagnostic value of this immune complex has not been fully ...
Maryam Arghiani   +7 more
doaj   +1 more source

Fibroblast Growth Factor 21 Attenuates Diabetes-Induced Renal Fibrosis by Negatively Regulating TGF-β-p53-Smad2/3-Mediated Epithelial-to-Mesenchymal Transition via Activation of AKT [PDF]

open access: yesDiabetes & Metabolism Journal, 2020
BackgroundEpithelial-to-mesenchymal transition (EMT) is required for renal fibrosis, which is a characteristic of diabetic nephropathy (DN). Our previous study demonstrated that fibroblast growth factor 21 (FGF21) prevented DN associated with the ...
Sundong Lin   +6 more
doaj   +1 more source

Complications of frontal defects [PDF]

open access: yes, 1987
A case where the severe course of an orbital phlegmon led to a functionally and cosmetically poor condition is presented. Thirty-five years later, it was possible to achieve a satisfactory result through several operations performed with ...
Berghaus, Alexander, Schmidt, B.
core   +1 more source

A systematic review of criteria used to report complications in soft tissue and oncologic surgical clinical research studies in dogs and cats. [PDF]

open access: yes, 2020
ObjectiveTo evaluate reporting of surgical complications and other adverse events in clinical research articles describing soft tissue and oncologic surgery in dogs and cats.Study designSystematic literature review.SampleEnglish-language articles ...
Balsa, Ingrid M   +7 more
core   +1 more source

Medications Activating Tubular Fatty Acid Oxidation Enhance the Protective Effects of Roux-en-Y Gastric Bypass Surgery in a Rat Model of Early Diabetic Kidney Disease

open access: yesFrontiers in Endocrinology, 2022
BackgroundRoux-en-Y gastric bypass surgery (RYGB) improves biochemical and histological parameters of diabetic kidney disease (DKD). Targeted adjunct medical therapy may enhance renoprotection following RYGB.MethodsThe effects of RYGB and RYGB plus ...
William P. Martin   +12 more
doaj   +1 more source

Endogenous FGF1 Deficiency Aggravates Doxorubicin-Induced Hepatotoxicity

open access: yesToxics, 2023
Doxorubicin (DOX) is a broad-spectrum antineoplastic agent that widely used in clinic. However, its application is largely limited by its toxicity in multiple organs. Fibroblast growth factor 1 (FGF1) showed protective potential in various liver diseases,
Chunjie Gu   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy